Viogen(PRIVATE)
A leader in animal cloning technology and services.
2 Insights
Investment Insights
AI-generated insights about Viogen from various financial sources
Tuesday, April 7, 2026
Very Bullish
Acquired by Colossal; provides high-efficiency cloning (78%) and a profitable consumer business to subsidize R&D.
Very Bullish
Target: 78% success rate
As a world leader in cloning, it significantly outperforms industry standard success rates and serves as a core component of the Colossal synthetic biology pipeline.
Tuesday, April 7, 2026
Very Bullish
Acquired by Colossal; provides high-efficiency cloning (78%) and a profitable consumer business to subsidize R&D.
Very Bullish
Target: 78% success rate
As a world leader in cloning, it significantly outperforms industry standard success rates and serves as a core component of the Colossal synthetic biology pipeline.